Richard M. Myers
Gründer bei SwitchGear Genomics, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
James R. Hudson | M | - |
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA.
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | 16 Jahre |
Sara Marsal | F | - |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | - |
Nathan D. Trinklein | M | - |
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA. | 18 Jahre |
Shelley Force Aldred | M | - |
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA. | 18 Jahre |
Fred Craves | M | 78 |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | - |
Neil Lamb | M | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Danny J. Windham | M | 64 |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
John R. Wynn | M | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Barbara Fisk-Nyland | F | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Paul Gierow | M | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Brian Stal | M | - |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | - |
Linda Smith | F | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Bob Riley | M | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Susan Ngo Vuong | F | - |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | 4 Jahre |
Manuel Lopez-Figueroa | M | - |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | 9 Jahre |
Deval Lashkari | M | 58 |
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA. | - |
Jack Ball | M | 77 |
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA. | - |
Irma Tuder | F | 62 |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
A. Eugene Sapp | M | 87 |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
J. Harris | M | 83 |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | 20 Jahre |
Sanford Zweifach | M | 68 |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | 5 Jahre |
Samuel P. McManus | M | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Brian Pollock | M | - |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 23 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Richard M. Myers
- Persönliches Netzwerk